• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Isle of Man·Financial Services·AGNMF
Share

Agronomics Limited Stocks

$ 0.06Last Updated 09.10.2026

Issuer Rating

2/7
Performance

Average

Risk

Critical

Recommendation

Sell

Market Cap

$ 75.40M

$ 0.06
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Agronomics Limited operates as a principal investment firm, deploying capital across various financial instruments, including funds, equity, and equity-linked products. Its portfolio encompasses both publicly traded and privately held companies. A primary emphasis is placed on pioneering sectors such as alternative proteins, particularly those involved in cellular agriculture and other emerging modern food technologies. The firm is also deeply committed to the biopharma sector, actively constructing a robust portfolio of investments in both biotechnology and pharmaceutical enterprises. Beyond direct equity, Agronomics may allocate capital to collective investment schemes concentrated on the biopharma industry, as well as long-term equity anticipation securities (LEAPS) whose underlying assets are biopharma-related stocks or indices. Additionally, the firm retains the option to invest in biopharma sector debt, though such exposures are capped at 15 percent of the company's net asset value. Established on May 3, 2011, Agronomics Limited is headquartered in Ramsey, Isle of Man.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is neutral on EV/EBITDA, underpriced on P/FC.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

11.10.2026 09:19

Twelve people were killed in an attack on the Riyadh airport

10.10.2026 16:01

What's Important in Small-Cap Stocks: Risks Associated with Webull, Levi's Outlook, and Vaxcyte's Success

10.10.2026 13:01

How soon will the AI bubble burst? Will France infect the Eurozone? What's wrong with Levi's jeans?

10.10.2026 06:47

Moderna hits four-year high as NYT reports U.S. cancer vaccine effort

10.10.2026 04:58

Palantir shares hit a new high: Barclays followed Goldman in recommending a buy

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026